RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized cell therapy trial offers hope for kids with Tough-to-Treat cancers
Disease control OngoingThis study is testing the safety and effectiveness of a personalized cell therapy called KTE-X19 for children and young adults up to age 21. The therapy is for those whose B-cell leukemia or lymphoma has come back or hasn't responded to other treatments. Doctors modify a patient'…
Matched conditions: RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Faster-Made Cancer-Fighting cells tested in major lymphoma trial
Disease control OngoingThis study is testing an experimental CAR-T cell therapy called GLPG5101 for people whose B-cell non-Hodgkin lymphoma has come back or hasn't responded to other treatments. The goal is to find the safest and most effective dose and see if this new therapy, which is made at the tr…
Matched conditions: RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Galapagos NV • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC